Fanyue Meng

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Fengcai Zhu, Fanyue Meng, Jingxin Li et al. · The Lancet · 2013 · 390 citations

Veterinary Medicine, Immunology, Pediatrics +12

A Novel Influenza A (H1N1) Vaccine in Various Age Groups

Fengcai Zhu, Hua Wang, Jian Guo Yang et al. · New England Journal of Medicine · 2009 · 341 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

Fengcai Zhu, Lihua Hou, Jingxin Li et al. · The Lancet · 2015 · 187 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial

Jingxin Li, Lihua Hou, Fanyue Meng et al. · The Lancet Global Health · 2016 · 101 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

Fengcai Zhu, Zhenglun Liang, Xiuling Li et al. · The Lancet · 2013 · 88 citations

Veterinary Medicine, Immunology, Infectious Diseases +15